Basic characteristics of patients and baseline data (intention to treat)
| Diclofenac patch (n = 60) | Placebo patch (n = 60) | |
|---|---|---|
| *Injured/contralateral. | ||
| Q1, lower quartile; Q3, upper quartile; SD, standard deviation. | ||
| Sex | ||
| Male, n (%) | 38 (63.3) | 35 (58.3) |
| Female, n (%) | 22 (36.7) | 25 (41.7) |
| Age (years) | ||
| Mean (median) | 31.6 (31) | 31.7 (32) |
| SD | 9.70 | 8.86 |
| Q1; Q3 | 25; 37 | 26; 37 |
| Height (cm) | ||
| Mean (median) | 177.2 (178.0) | 176.2 (174.5) |
| SD | 8.20 | 10.30 |
| Q1; Q3 | 171; 182 | 168; 183 |
| Weight (kg) | ||
| Mean (median) | 71.3 (72) | 71.6 (69) |
| SD | 12.03 | 14.06 |
| Q1; Q3 | 62; 80 | 64; 78 |
| Tenderness injured area (kp/cm2) | ||
| Mean (median) | 1.5 (1.3) | 1.4 (1.3) |
| SD | 0.77 | 0.67 |
| Q1; Q3 | 1.0; 2.0 | 0.9; 1.8 |
| Tenderness contralateral area (kp/cm2) | ||
| Mean (median) | 5.1 (4.8) | 4.7 (4.4) |
| SD | 1.43 | 1.39 |
| Q1; Q3 | 4.0; 6.1 | 3.8; 5.4 |
| Ratio of tenderness values* | ||
| Mean (median) | 0.28 (0.28) | 0.29 (0.29) |
| SD | 0.08 | 0.09 |
| Q1; Q3 | 0.23; 0.33 | 0.23; 0.36 |
| VAS at rest (mm) | ||
| Mean (median) | 63 (66) | 63 (67) |
| SD | 23.5 | 25.3 |
| Q1; Q3 | 44; 81 | 44; 85 |
| VAS in motion (mm) | ||
| Mean | 75 (78) | 74 (78) |
| SD | 20.0 | 22.6 |
| Q1; Q3 | 65; 92 | 56; 95 |
| Location of injury, n (%) | ||
| Arm | 26 (43.3) | 28 (46.7) |
| Leg | 31 (51.7) | 30 (50.0) |
| Other | 3 (5.0) | 2 (3.3) |